BofA downgrades Alexandria Real Estate stock rating on earnings concerns
BofA Securities downgraded Alexandria Real Estate Equities (NYSE:ARE) to Underperform, lowering its price target to $45 from $55. The company reported a $8.40 per share loss and 9.77% revenue decline over the last year, despite a 6.5% dividend yield. BofA cited declining earnings and leasing challenges as reasons for the downgrade. Alexandria's Q3 2026 results showed mixed performance, with revenue exceeding estimates but significant earnings loss due to real estate impairments.
How this was made
The 30-second read
Why it matters
Analyst downgrade signals potential short-term downside, but the company's dividend yield and cash position may support stability.
Market read
The downgrade introduces fresh negative sentiment for ARE and may influence peer REITs.
What to watch
Strong leasing activity and solid liquidity could mitigate the earnings decline over the longer term.
Background
The downgrade follows ARE's Q3 2026 results, which showed a loss per share and revenue decline, but also higher occupancy and robust leasing.
Ticker impact
BofA downgraded Alexandria Real Estate Equities to Underperform and cut its price target to $45, citing earnings decline and higher vacancy risk.
likely pressure as investors price in weaker earnings outlook and reduced target.
Downgrade is a fresh, material analyst action affecting valuation; market typically reacts negatively to such changes.
Market effects
Healthcare REITs may face broader scrutiny as earnings concerns rise.
U.S. REIT sector could see modest sell pressure.
Limited to U.S. markets; no immediate global ripple.
Counterpoint
If the dividend yield remains attractive, some investors may view the price dip as a buying opportunity.
Key entities
- companyAlexandria Real Estate Equities
Healthcare-focused REIT (NYSE:ARE) receiving a downgrade.
- analystBofA Securities
Downgraded ARE to Underperform and cut price target.



